Orazi, Lorenzo
 Distribuzione geografica
Continente #
EU - Europa 264
NA - Nord America 224
AS - Asia 98
AF - Africa 4
SA - Sud America 3
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 596
Nazione #
US - Stati Uniti d'America 221
DE - Germania 60
SE - Svezia 53
IT - Italia 42
SG - Singapore 34
CN - Cina 26
FR - Francia 21
IE - Irlanda 17
MK - Macedonia 12
FI - Finlandia 11
GB - Regno Unito 11
RU - Federazione Russa 11
ID - Indonesia 10
RS - Serbia 8
IN - India 6
UA - Ucraina 6
TR - Turchia 5
BE - Belgio 4
EG - Egitto 4
IR - Iran 4
CZ - Repubblica Ceca 3
HK - Hong Kong 3
PE - Perù 3
CA - Canada 2
CH - Svizzera 2
KR - Corea 2
NZ - Nuova Zelanda 2
PH - Filippine 2
CY - Cipro 1
DK - Danimarca 1
IL - Israele 1
JP - Giappone 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NL - Olanda 1
PA - Panama 1
PL - Polonia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 596
Città #
Chandler 50
Singapore 30
Ashburn 27
New York 18
Dublin 17
Rome 13
Marseille 12
Helsinki 10
Jakarta 10
Skopje 10
Los Angeles 6
Moscow 6
Niš 6
Milan 5
Pune 5
Boston 4
Brussels 4
Cairo 4
Jacksonville 4
Munich 4
Princeton 4
Bremen 3
Lima 3
London 3
Nanchang 3
Paris 3
Ankara 2
Atlanta 2
Auckland 2
Bari 2
Bauang 2
Boardman 2
Brno 2
Cattolica 2
Changchun 2
Dearborn 2
Frankfurt am Main 2
Hangzhou 2
Harrisburg 2
Hong Kong 2
Houston 2
Novi Sad 2
Pavia 2
Romainville 2
San Mateo 2
Shenzhen 2
Ann Arbor 1
Beijing 1
Bern 1
Brdo 1
Buffalo 1
Central 1
Changsha 1
Chicago 1
Columbus 1
Fairfield 1
Freiburg im Breisgau 1
Kashan 1
Kish 1
Kunming 1
Lancaster 1
Lausanne 1
Lawrence 1
Liverpool 1
Lviv 1
Macao 1
Meizhou 1
Montreal 1
Mountain View 1
Nanjing 1
Nanyang 1
Nicosia 1
Ningbo 1
Nuremberg 1
Pristina 1
Reading 1
Royal Oak 1
Sanremo 1
Seattle 1
Secaucus 1
Seongnam-si 1
Seoul 1
Shanghai 1
Suzhou 1
Taichung 1
Tokyo 1
Toronto 1
Valle 1
Vignanello 1
Warsaw 1
Washington 1
Watertown 1
Wuhu 1
Xi'an 1
Totale 352
Nome #
Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings 168
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 85
Short- and mid-term multidisciplinary outcomes of newborns exposed to SARS-CoV-2 in utero or during the perinatal period: preliminary findings 59
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 57
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 51
The role of retinal imaging in the management of abusive head trauma cases 49
Visual function and ophthalmological findings in CHARGE syndrome: Revision of literature, definition of a new clinical spectrum and genotype phenotype correlation 49
Risdiplam in Type 1 Spinal Muscular Atrophy 40
Visual Function in Children with GNAO1-Related Encephalopathy 26
Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study (Neurology and Therapy, (2023), 12, 2, (543-557), 10.1007/s40120-023-00444-1) 20
Totale 604
Categoria #
all - tutte 3.523
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.523


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0 0 0 0 0 9 3 1 2 2 1 2
2020/202110 0 1 0 1 3 0 0 0 1 1 2 1
2021/202242 2 1 0 0 0 0 0 1 1 7 11 19
2022/2023223 19 31 12 27 7 20 14 14 51 5 12 11
2023/2024148 7 25 3 13 3 37 11 7 2 7 15 18
2024/202585 6 3 18 14 24 20 0 0 0 0 0 0
Totale 604